Vulcan Energy's Own Adsorbent Hits 95% as the Market Waits for the Bill

Vulcan Energy began commercial VULSORB adsorbent production as its stock fell 46% year-to-date, with Lionheart financing still unresolved.

Vulcan Energy has crossed a line few European lithium hopefuls ever reach: it now produces its own extraction chemistry. The company's alumina-based adsorbent, VULSORB, has entered commercial production and is destined to serve as the first fill for the extraction columns at its future processing plants. In industrial trials spanning thousands of operating cycles with geothermal brine, the material delivered lithium extraction efficiency of as much as 95%.

That figure matters beyond the laboratory. With China having imposed strict export controls on modern direct extraction technologies, Europe's push for protected value chains has turned urgent, and Vulcan's decision to manufacture VULSORB with European partners — under Western intellectual property — is designed to insulate the project from geopolitical restrictions and trade frictions over the long haul. CEO Cris Moreno framed the shielded supply chain as a meaningful reduction of the company's operational risk profile.

A Share Price That Tells a Different Story

Investors, however, are not pricing in applause. The stock closed Tuesday at EUR 1.38, down 46% since the start of the year, and touched a fresh 52-week low of EUR 1.35 during the session. On a separate reading, the shares sat at EUR 1.36 with a year-to-date decline of 47%, putting the company's market capitalization at EUR 659.98 million. Either way, the message from the market is the same: permitting wins and technical milestones are being met with a shrug.

What investors want instead is hard evidence that the jump from development to construction can happen without wiping out existing shareholders. The company's founder, Dr. Francis Wedin, has moved into an advisory role to concentrate on the project pipeline and the VULTEC technology unit — a shift that could speed up technical execution.

Lionheart's Output and the Ludwig Price Tag

At the heart of the plan sits Lionheart in the Upper Rhine Valley, targeting 24,000 tonnes of lithium hydroxide monohydrate per year — enough, by the company's math, to equip roughly 500,000 electric vehicles. Over a projected 30-year operating life, the facility would also generate renewable electricity and heat alongside the battery raw material.

The expansion stage, Project Ludwig near Ludwigshafen, carries an estimated development cost of EUR 1.26 billion, according to its pre-feasibility study. On a comparable capacity basis, that is about 15% below the calculated figures for the Lionheart pilot. Ludwig's own blueprint calls for 30 years of operation, 21,100 tonnes of battery-grade lithium carbonate annually and the feed-in of 3,125 gigawatt hours of renewable heat per year. Beyond Lionheart and Ludwig, Vulcan is weighing further uses for its in-house process, including worldwide licensing of selected technologies through VULTEC.

Where the Story Could Break

The financing of both projects remains management's tallest hurdle. If strategic partners or public subsidies cannot be brought in at sufficient scale, large capital increases loom — and those would visibly dilute the existing shareholder base. Until Lionheart's targeted commissioning in the second half of 2028, the company faces a long stretch of heavy upfront costs with no meaningful operating cash inflow, leaving it exposed to rising drilling and plant-construction expenses. Delayed build-outs or additional regulatory obstacles would only push the capital requirement higher.

International raw material markets add their own uncertainty. A sustained low price level for lithium compounds could undermine the economics of the planned volumes and make financing partners more cautious, driving up funding costs. In that scenario, shareholders would have to brace for further valuation markdowns if milestones slip.

What to Watch Next

The recovery case holds as long as the recent interim low is defended and binding financing commitments for plant construction are announced. If the cost and output profile is confirmed over time, the market could once again give more weight to the technological progress. Should sentiment sour further, or should delays emerge in assembling the necessary billions, a retest of the lows becomes the risk. The decisive catalyst is the final financing structure for Lionheart — and until that lands, binding partnership and offtake agreements remain the truest gauge of investor confidence.